Stefania Paolini

Years Active: 2021-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Naval G Daver, Monique Dail, Jacqueline S Garcia, Brian A Jonas, Karen W L Yee, Kevin R Kelly, Norbert Vey, Sarit Assouline, Gail J Roboz, Stefania Paolini, Daniel A Pollyea, Agostino Tafuri, Joseph M Brandwein, Arnaud Pigneux, Bayard L Powell, Pierre Fenaux, Rebecca L Olin, Giuseppe Visani, Giovanni Martinelli, Maika Onishi, Jue Wang, Weize Huang, Cherie Green, Marion G Ott, Wan-Jen Hong, Marina Y Konopleva, Michael Andreeff
Venetoclax and idasanutlin in relapsed/refractory AML: a non-randomized, open-label phase 1b trial. Blood (2022)
Simone Ragaini, Sarah Wagner, Giovanni Marconi, Sarah Parisi, Chiara Sartor, Jacopo Nanni, Gianluca Cristiano, Annalisa Talami, Matteo Olivi, Darina Ocadlikova, Marilena Ciciarello, Giulia Corradi, Emanuela Ottaviani, Cristina Papayannidis, Stefania Paolini, Jayakumar Vadakekolathu, Michele Cavo, Sergio Rutella, Antonio Curti
An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemia. Blood advances (2021)

Stefania Paolini.css-eqlu8i{font-size:small;padding-left:4px;}